Acciones Callitas Health Inc. Canadian Securities Exchange
Acciones
LILY
CA13125C1068
Biotecnología e investigación médica
Ventas 2018 | 0,75 1,03 0,7 | Ventas 2019 | 0,71 0,97 0,66 | Capitalización | 3,53 M 4,82 M 3,27 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -6,84 M -4,64 M | Resultado Neto 2019 | -1 M -1,37 M -927 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 436 mil 296 mil | Deuda neta 2019 | 848 mil 1,16 M 786 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,37 % | 48,16 mil M | |
-1,01 % | 41,73 mil M | |
+46,00 % | 41,03 mil M | |
-5,31 % | 28,77 mil M | |
+9,34 % | 25,59 mil M | |
-21,69 % | 18,96 mil M | |
+6,23 % | 12,92 mil M | |
+26,99 % | 12,03 mil M | |
-3,38 % | 11,77 mil M |